Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.h

Path: Pulmonary necrotizing granuloma with neutrophilic microabscesses

Publications

Myc LA, Girton MR, Stoler MH, Davis EM

Necrobiotic Pulmonary Nodules of Crohn's Disease in a Patient Receiving Vedolizumab.

American journal of respiratory and critical care medicine 2019 Jan 01;199;e1-e2 — 2019 Jan 01 — e1-e2